Peer Review reports
From: Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
| Original Submission | ||
|---|---|---|
| 29 Sep 2020 | Submitted | Original manuscript |
| 17 Nov 2020 | Reviewed | Reviewer Report - Helmout Modjtahedi |
| 25 Nov 2020 | Reviewed | Reviewer Report |
| 30 Dec 2020 | Author responded | Author comments - Wendy Bernhard |
| Resubmission - Version 2 | ||
| 30 Dec 2020 | Submitted | Manuscript version 2 |
| 18 Jan 2021 | Reviewed | Reviewer Report - Helmout Modjtahedi |
| 18 Feb 2021 | Reviewed | Reviewer Report |
| 28 Feb 2021 | Author responded | Author comments - Wendy Bernhard |
| Resubmission - Version 3 | ||
| 28 Feb 2021 | Submitted | Manuscript version 3 |
| Publishing | ||
| 2 Mar 2021 | Editorially accepted | |
| 12 Mar 2021 | Article published | 10.1186/s12885-021-08003-3 |
You can find further information about peer review here.